ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 992,87
0,18%
Dow Jones
38 686,32
1,51%
DAX
18 497,94
-0,09%
Brent Oil
81,03
0,28%
Bitcoin
68 465,08
1,06%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. ProMIS Neurosciences Inc (PMN)

  7. ProMIS Neurosciences Inc (PMN) Actualités

PMN

ProMIS Neurosciences (PMN)

ProMIS Neurosciences Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PMN
DateHeureSourceTitreSymboleSociété
14/05/202422h25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PMNProMIS Neurosciences Inc
14/05/202422h01GlobeNewswire Inc.ProMIS Neurosciences Announces First Quarter 2024 Financial Results and Recent HighlightsNASDAQ:PMNProMIS Neurosciences Inc
30/04/202413h00GlobeNewswire Inc.ProMIS Neurosciences Publishes Study Highlighting Oligomer Selectivity and Benefit of Amyloid-Beta-Directed AntibodiesNASDAQ:PMNProMIS Neurosciences Inc
09/04/202413h00GlobeNewswire Inc.ProMIS Neurosciences Publishes in the Journal of Biological Chemistry on the Interaction Between Pathogenic Proteins as a Treatment Target for ALSNASDAQ:PMNProMIS Neurosciences Inc
04/04/202413h00GlobeNewswire Inc.ProMIS Neurosciences to Present in Upcoming Investor Conferences in April NASDAQ:PMNProMIS Neurosciences Inc
01/04/202422h15GlobeNewswire Inc.ProMIS Neurosciences Announces Full Year 2023 Financial Results and Recent HighlightsNASDAQ:PMNProMIS Neurosciences Inc
11/03/202412h00GlobeNewswire Inc.ProMIS Neurosciences Strengthens Global Intellectual Property PortfolioNASDAQ:PMNProMIS Neurosciences Inc
22/02/202413h00GlobeNewswire Inc.ProMIS Neurosciences to Present at the 2024 BIO CEO & Investor ConferenceNASDAQ:PMNProMIS Neurosciences Inc
22/01/202413h00GlobeNewswire Inc.ProMIS Neurosciences Achieves Milestone in Development of Therapeutic Alpha-Synuclein VaccineNASDAQ:PMNProMIS Neurosciences Inc
08/01/202413h00GlobeNewswire Inc.ProMIS Neurosciences Issues Letter to ShareholdersNASDAQ:PMNProMIS Neurosciences Inc
03/01/202413h00GlobeNewswire Inc.ProMIS Neurosciences, Inc. Announces Leadership TransitionNASDAQ:PMNProMIS Neurosciences Inc
20/12/202313h00GlobeNewswire Inc.ProMIS Neurosciences Announces Publication on Novel Target for ALSNASDAQ:PMNProMIS Neurosciences Inc
20/11/202313h00GlobeNewswire Inc.ProMIS Neurosciences Doses First Subjects in Phase 1a Clinical Trial of PMN310 to Treat Alzheimer’s DiseaseNASDAQ:PMNProMIS Neurosciences Inc
14/11/202322h30GlobeNewswire Inc.ProMIS Neurosciences Announces Third Quarter 2023 Financial Results and Recent HighlightsNASDAQ:PMNProMIS Neurosciences Inc
08/09/202313h00GlobeNewswire Inc.ProMIS Neurosciences Closes $20.4 Million Private Placement FinancingNASDAQ:PMNProMIS Neurosciences Inc
06/09/202318h18GlobeNewswire Inc.ProMIS Neurosciences to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:PMNProMIS Neurosciences Inc
21/08/202322h12GlobeNewswire Inc.ProMIS Neurosciences Announces $20.4 Million Private Placement FinancingNASDAQ:PMNProMIS Neurosciences Inc
14/08/202323h33GlobeNewswire Inc.ProMIS Neurosciences Announces Second Quarter 2023 Financial Results and Recent HighlightsNASDAQ:PMNProMIS Neurosciences Inc
17/07/202313h00GlobeNewswire Inc.ProMIS Showcases Preclinical Data at the Alzheimer’s Association International Conference 2023 on Computationally-Derived Antibody and Vaccine from Alzheimer’s PipelineNASDAQ:PMNProMIS Neurosciences Inc
14/07/202313h45GlobeNewswire Inc.ProMIS Announces Completion of ContinuanceNASDAQ:PMNProMIS Neurosciences Inc
10/07/202313h55GlobeNewswire Inc.ProMIS Neurosciences to Consolidate Trading on the Nasdaq ExchangeNASDAQ:PMNProMIS Neurosciences Inc
30/06/202314h00GlobeNewswire Inc.ProMIS Neurosciences Holds Annual Meeting of Shareholders All Resolutions ApprovedNASDAQ:PMNProMIS Neurosciences Inc
29/06/202314h00GlobeNewswire Inc.CORRECTION: Updated URL to Access ProMIS Annual Meeting of Shareholders on June 29, 2023 at 9:30am Eastern TimeNASDAQ:PMNProMIS Neurosciences Inc
15/05/202323h00GlobeNewswire Inc.ProMIS Neurosciences Announces First Quarter 2023 Financial Results and Recent HighlightsNASDAQ:PMNProMIS Neurosciences Inc
08/05/202315h00GlobeNewswire Inc.ProMIS Neurosciences Announces FDA Clearance of Investigational New Drug (IND) Application for PMN310 in Alzheimer’s DiseaseNASDAQ:PMNProMIS Neurosciences Inc
25/04/202323h00GlobeNewswire Inc.Data Presented at American Academy of Neurology Annual Meeting on Novel Vaccine Design for Alzheimer’s DiseaseNASDAQ:PMNProMIS Neurosciences Inc
24/04/202313h30GlobeNewswire Inc.ProMIS Neurosciences Presents Preclinical Data Highlighting Targeting of Toxic Misfolded Proteins in Alzheimer’s Disease and ALS at American Academy of Neurology Annual MeetingNASDAQ:PMNProMIS Neurosciences Inc
10/04/202313h30GlobeNewswire Inc.ProMIS Neurosciences Announces Submission of Investigational New Drug (IND) Application for Lead Antibody PMN310NASDAQ:PMNProMIS Neurosciences Inc
29/03/202314h30GlobeNewswire Inc.Lead Therapeutic Candidate, PMN310, Demonstrates Enhanced Selectivity for Toxic Oligomers Compared to Other Amyloid-Beta-Directed Antibodies in Poster Presentation at AD/PD 2023NASDAQ:PMNProMIS Neurosciences Inc
13/03/202314h00GlobeNewswire Inc.ProMIS Neurosciences Announces Abstracts Accepted for Presentation at the American Academy of Neurology 2023 Annual MeetingNASDAQ:PMNProMIS Neurosciences Inc
 Showing the most relevant articles for your search:NASDAQ:PMN

Dernières Valeurs Consultées

EU
ORA
Orange
NASDAQ
NVDA
NVIDIA
EU
GLE
Societe Generale
EU
RNO
Renault
NYSE
DIS
Walt Disney
NYSE
MCD
McDonalds
EU
BEL20
Bel 20
EU
BNP
BNP Paribas
EU
ACA
Credit Agricole
EU
PX1
CAC 40
EU
EN
Bouygues
NASDAQ
AAPL
Apple
EU
SGO
Cie de SaintGobain
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés